share_log

君聖泰醫藥-B：非執行董事辭任

HIGHTIDE-B: RESIGNATION OF NON-EXECUTIVE DIRECTOR

Hong Kong Stock Exchange ·  Feb 2 16:39
Summary by Futu AI
君聖泰醫藥-B（股份代號：2511）於2024年2月2日宣布，非執行董事李鋰先生已因個人事務需投入更多時間而辭任，該辭任將自同日起生效。李先生確認與董事會無任何意見分歧，且無需特別通知股東或香港聯合交易所有限公司。董事會對李先生在任期內對公司的貢獻表示感謝。目前董事會成員包括執行董事劉利平博士及于萌女士，非執行董事朱迅博士、馬立雄先生及江峰先生，以及獨立非執行董事譚擘先生、李靖博士及孔德偉先生。
君聖泰醫藥-B（股份代號：2511）於2024年2月2日宣布，非執行董事李鋰先生已因個人事務需投入更多時間而辭任，該辭任將自同日起生效。李先生確認與董事會無任何意見分歧，且無需特別通知股東或香港聯合交易所有限公司。董事會對李先生在任期內對公司的貢獻表示感謝。目前董事會成員包括執行董事劉利平博士及于萌女士，非執行董事朱迅博士、馬立雄先生及江峰先生，以及獨立非執行董事譚擘先生、李靖博士及孔德偉先生。
JUN SHENG TAI PHARMACEUTICAL-B (STOCK CODE: 2511) ANNOUNCED ON 2 FEBRUARY 2024 THAT NON-EXECUTIVE DIRECTOR MR. LI LITHI HAS RESIGNED DUE TO THE NEED TO INVEST MORE TIME IN PERSONAL MATTERS AND WILL TAKE EFFECT FROM THE SAME DATE. Mr. Li confirms that there is no disagreement with the Board of Directors and that no special notice is required to the shareholders or the HKEX Limited. The Board of Directors expressed its gratitude to Mr. Lee for his contributions to the Company during his tenure. Current Board members include Executive Directors Dr. Liu Liping and Ms. Yu Meng, Non-Executive Directors Dr. Zhu Xun, Mr. Ma Li-Hung and Mr. Jiang Feng, and Independent Non-Executive Directors Mr. Tan Yin, Dr. Li Jing and Mr. Kung De Wai.
JUN SHENG TAI PHARMACEUTICAL-B (STOCK CODE: 2511) ANNOUNCED ON 2 FEBRUARY 2024 THAT NON-EXECUTIVE DIRECTOR MR. LI LITHI HAS RESIGNED DUE TO THE NEED TO INVEST MORE TIME IN PERSONAL MATTERS AND WILL TAKE EFFECT FROM THE SAME DATE. Mr. Li confirms that there is no disagreement with the Board of Directors and that no special notice is required to the shareholders or the HKEX Limited. The Board of Directors expressed its gratitude to Mr. Lee for his contributions to the Company during his tenure. Current Board members include Executive Directors Dr. Liu Liping and Ms. Yu Meng, Non-Executive Directors Dr. Zhu Xun, Mr. Ma Li-Hung and Mr. Jiang Feng, and Independent Non-Executive Directors Mr. Tan Yin, Dr. Li Jing and Mr. Kung De Wai.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.